Discover 884 paid clinical trials in Daytona Beach, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 884
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Orlando FL, Ft. Pierce FL, Sarasota FL,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase 2, Phase 3, Recruiting
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Orlando FL, The Villages FL, New Port Richey FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Orlando FL, The Villages FL, New Port Richey FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & Responsive
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
for
Treatment Resistant Depression
Location: Orlando FL, Tampa FL, Boca Raton FL, Hialeah FL,
Sponsor: LivaNova
Sex: All
Age: 18+
Code: NCT03887715
Recruiting
Active & Responsive
Prospective Outcomes Study: Vectra® DA Guided Care Compared to Usual Care
Get alerts for new trials in your area by subscribing now
Active & Responsive
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
for
PIK3CA Mutation, Solid Tumor, Adult,
Location: Orlando FL, Nashville TN, Fairfax VA, Indianapolis IN,
Sponsor: Relay Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT05216432
Phase 1, Recruiting
Active & Responsive
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: Orlando FL, Jacksonville FL, Tampa FL, Coral Springs FL,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07277413
Phase 1, Recruiting
Active & Responsive
Evaluation of RAS Inhibitor Treatment in Participants With Advanced or Metastatic Solid Tumors Harboring RAS Mutations
for
Solid Tumors (Phase 1), RAS Mutation
Location: Orlando FL, Houston TX
Sponsor: Adlai Nortye Biopharma Co., Ltd.
Sex: All
Age: 18+
Code: NCT07252479
Phase 1, Recruiting
Active & Responsive
A Clinical Trial to Test if the Investigational Drug BNT329 is Safe and Potentially Beneficial for People With Advanced Solid Tumors Known to Express the Tumor Marker CA19-9
for
Advanced Solid Cancers
Location: Orlando FL, New York NY, Detroit MI, Denver CO
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07186842
Phase 1, Phase 2, Recruiting
Active & Responsive
A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer